All sites C00-96,D32-33,D42-43,D45-47,D76 703 91.2 1.8 2.2 1.1 3.6
Mouth, pharynx C00-14 12 98.3 1.7 - - -
  Lip C00 2 100.0 - - - -
  Tongue C02 4 100.0 - - - -
  Mouth, other C03-06 3 100.0 - - - -
  Salivary glands C07-08 1 83.3 16.7 - - -
  Pharynx C01,C09-14 2 100.0 - - - -
Digestive organs C15-26 133 89.0 0.8 3.9 2.1 4.2
  Oesophagus C15 5 96.3 - - 3.7 -
  Stomach C16 13 100.0 - - - -
  Small intestine C17 2 100.0 - - - -
  Colon C18 48 95.4 - 1.3 0.4 2.9
  Rectum, rectosigmoid C19-20 23 97.4 - 0.9 0.9 0.9
  Anus C21 1 100.0 - - - -
  Liver C22 6 93.5 - 6.5 - -
  Gallbladder, bile ducts C23-24 5 66.7 3.7 7.4 11.1 11.1
  Pancreas C25 27 68.7 3.0 13.4 5.2 9.7
  Other digestive organs C26 2 50.0 - - 10.0 40.0
Respiratory organs C30-39 40 75.1 7.0 9.0 3.5 5.5
  Nose, sinuses C30-31 1 100.0 - - - -
  Larynx, epiglottis C32 0 100.0 - - - -
  Lung, trachea C33-34 38 75.3 7.4 8.9 3.7 4.7
  Mediastinum, pleura C38 0 - - 100.0 - -
Bone C40-41 2 100.0 - - - -
Melanoma of the skin C43 28 100.0 - - - -
Skin, non-melanoma C44 35 99.4 - - - 0.6
Mesothelioma C45 1 83.3 16.7 - - -
Autonomic nervous system C47 1 100.0 - - - -
Soft tissues C48-49 4 94.7 - - 5.3 -
Breast C50 210 99.2 0.2 - 0.1 0.5
Female genital organs C51-58 81 92.1 1.0 2.7 2.7 1.5
  Cervix uteri C53 7 100.0 - - - -
  Corpus uteri C54 38 97.4 - 1.1 1.1 0.5
  Uterus, other C55,C58 1 75.0 - - 25.0 -
  Ovary C56 24 86.0 2.5 6.6 2.5 2.5
  Other female genital C51-52,C57 11 83.6 1.8 1.8 9.1 3.6
Urinary organs C64-68 32 91.4 1.2 4.3 - 3.1
  Kidney C64 18 89.8 - 6.8 - 3.4
  Bladder and urinary tract2 C65-68 15 93.2 2.7 1.4 - 2.7
Eye C69 0 100.0 - - - -
Brain, central nervous system C70-72,D32-33,D42-43 25 91.9 - 1.6 0.8 5.6
Thyroid gland C73 14 95.8 1.4 1.4 - 1.4
Other endocrine glands C74-75 0 100.0 - - - -
Illdefined or unknown C76,C80 19 57.0 9.7 15.1 3.2 15.1
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 67 77.6 7.2 - 0.6 14.6
  Hodgkin lymphoma C81 2 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 30 96.1 2.0 - - 2.0
  Malignant immunoproliferative diseases C88 1 75.0 - - - 25.0
  Myeloma and other plasma cell tumors C90 8 55.0 10.0 - 5.0 30.0
  Leukaemia C91-95 18 73.6 13.2 - - 13.2
  Myelodysplastic syndromes D46 3 6.3 31.3 - - 62.5
  Myeloproliferaitive neoplasms D45,D47 4 47.6 - - - 52.4
Not included above
  Carcinoma in situ of the breast D05 11 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 18 100.0 - - - -
  Borderline tumour of the ovary D39 6 100.0 - - - -
  Basal cell carcinoma of the skin 124 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.